OtherClinical Investigations (Human)
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography
Simone Krebs, Darren R Veach, Lukas M Carter, Milan Grkovski, Monica Fornier, Michael J Mauro, Martin H Voss, Daniel C Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley Jay Beattie, Pat B. Zanzonico, Wolfgang Andreas Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson and Mark P.S. Dunphy
Journal of Nuclear Medicine March 2020, jnumed.119.234864; DOI: https://doi.org/10.2967/jnumed.119.234864
Simone Krebs
1 Memorial Sloan Kettering Cancer Center, United States;
Darren R Veach
1 Memorial Sloan Kettering Cancer Center, United States;
Lukas M Carter
1 Memorial Sloan Kettering Cancer Center, United States;
Milan Grkovski
1 Memorial Sloan Kettering Cancer Center, United States;
Monica Fornier
1 Memorial Sloan Kettering Cancer Center, United States;
Michael J Mauro
1 Memorial Sloan Kettering Cancer Center, United States;
Martin H Voss
1 Memorial Sloan Kettering Cancer Center, United States;
Daniel C Danila
1 Memorial Sloan Kettering Cancer Center, United States;
Eva Burnazi
1 Memorial Sloan Kettering Cancer Center, United States;
Manda Null
1 Memorial Sloan Kettering Cancer Center, United States;
Kevin Staton
1 Memorial Sloan Kettering Cancer Center, United States;
Christina Pressl
2 The Rockefeller University;
Bradley Jay Beattie
1 Memorial Sloan Kettering Cancer Center, United States;
Pat B. Zanzonico
3 Memorial Sloan-Kettering Cancer Center;
Wolfgang Andreas Weber
4 Technical University of Munich
Serge K. Lyashchenko
1 Memorial Sloan Kettering Cancer Center, United States;
Jason S. Lewis
3 Memorial Sloan-Kettering Cancer Center;
Steven M. Larson
3 Memorial Sloan-Kettering Cancer Center;
Mark P.S. Dunphy
1 Memorial Sloan Kettering Cancer Center, United States;

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography
Simone Krebs, Darren R Veach, Lukas M Carter, Milan Grkovski, Monica Fornier, Michael J Mauro, Martin H Voss, Daniel C Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley Jay Beattie, Pat B. Zanzonico, Wolfgang Andreas Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson, Mark P.S. Dunphy
Journal of Nuclear Medicine Mar 2020, jnumed.119.234864; DOI: 10.2967/jnumed.119.234864
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography
Simone Krebs, Darren R Veach, Lukas M Carter, Milan Grkovski, Monica Fornier, Michael J Mauro, Martin H Voss, Daniel C Danila, Eva Burnazi, Manda Null, Kevin Staton, Christina Pressl, Bradley Jay Beattie, Pat B. Zanzonico, Wolfgang Andreas Weber, Serge K. Lyashchenko, Jason S. Lewis, Steven M. Larson, Mark P.S. Dunphy
Journal of Nuclear Medicine Mar 2020, jnumed.119.234864; DOI: 10.2967/jnumed.119.234864
Jump to section
Related Articles
Cited By...
- No citing articles found.